August 28, 2014 12:58 PM ET

Healthcare Providers and Services

Company Overview of Genzyme Polyclonals S.A.S.

Company Overview

Genzyme Polyclonals S.A.S. operates as a subsidiary of Genzyme Corporation.

Les Carrés du Parc

10 rue des Rosiéristes - BP 54

Champagne au Mont D´Or

Rhone,  69543



33 4 37 28 16 00


33 4 37 28 16 79

Key Executives for Genzyme Polyclonals S.A.S.

Chief Executive Officer and Chief Operating Officer
Age: 59
Compensation as of Fiscal Year 2014.

Genzyme Polyclonals S.A.S. Key Developments

Genzyme Presents at Boston CEO Conference, Jun-05-2014 04:00 PM

Genzyme Presents at Boston CEO Conference, Jun-05-2014 04:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: David Meeker.

Genzyme Receives Complete Response Letter from Food and Drug Administration on Lemtrada(TM) (alemtuzumab) Application

Genzyme announced that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A complete response letter informs companies that an application is not ready for approval. FDA has taken the position that the company has not submitted evidence from adequate and well-controlled studies that demonstrate the benefits of Lemtrada outweigh its serious adverse effects. The company understands that the conclusion is related to the design of the completed Phase 3 active comparator studies of Lemtrada in relapsing-remitting MS patients. FDA has also taken the position that one or more additional active comparator clinical trials of different design and execution are needed prior to the approval of Lemtrada.

Sanofi Announces New Partnership with Genzyme

Sanofi and Genzyme announced a new partnership. Genzyme and Sanofi target their philanthropic giving toward areas of need in communities, with particular focus on science and education, including organizations that foster the next generation of diverse STEM leaders. The College of Science and Mathematics has developed a highly successful program for advancing student success in STEM majors. This program revamped advising, academic support, and orientation, and developed a learning community program as the centerpiece of this strategy. Retention in the program is more than 15 points above the college's preexisting levels, with large increases of students remaining in STEM majors.

Similar Private Companies By Industry

Company Name Region
Hologic Switzerland SARL Europe
Clinique Chantecler Europe
Labco S.A.S. Europe
Analyse du Risque Medical Europe
M3G Distribution Europe

Recent Private Companies Transactions

March 10, 2014
Celsior Solution

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genzyme Polyclonals S.A.S., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at